GGrantIndex
Sort

130,381 grants matching hiv

Multicenter AIDS Cohort Study

$3,552,111
Steven M Wolinsky · Northwestern University At Chicago · U01 · FY2015 · AI

Multicenter AIDS Cohort Study - Part B (Baltimore Center)

$3,551,227
Joseph B. Margolick · Johns Hopkins University · U01 · FY2010 · AI

GH11-1114, Strengthening HIV Clinical Care and Treatment

$3,550,810
Dianne Jean Francois · Catholic Medical Mission Board, Inc. · U2G · FY2016 · GH

HIV PREVENTION TRIAL UNIT

$3,550,212
University Of Pennsylvania · U01 · FY2002 · AI

SUPPORTING THE SCALE-UP OF HIGH QUALITY HIV CARE AND TREATMENT PROGRAMS IN

$3,550,000
Carol Porter · Howard University · U2G · FY2011 · PS

Miami Clinical and Translational Science Institute

$3,549,587
Ralph Lewis Sacco · University Of Miami School Of Medicine · UL1 · FY2019 · TR

Miami Clinical and Translational Science Institute

$3,549,587
Ralph Lewis Sacco · University Of Miami School Of Medicine · UL1 · FY2020 · TR

Novel Heterologous Adenovirus Prime-Boost HIV-1 Vaccine

$3,549,203
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI

International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network

$3,548,875
Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2021 · AI

Novel VLP-Based Mucosal and Sytemic HIV Vaccines

$3,545,652
Jiri F Mestecky · University Of Alabama At Birmingham · U19 · FY2007 · AI

SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS

$3,544,291
Barbara Driver · Westat, Inc. · N01 · FY2023 · HD

HARC Center: HIV Accessory and Regulatory Complexes

$3,544,248
Alan D Frankel · University Of California, San Francisco · P50 · FY2008 · GM

Operations and Management support component

$3,544,156
Barton F Haynes · Duke University · UM1 · FY2016 · AI

CoVPN 3005: Efficacy, Immunogenicity, and Safety of Two SARS-CoV-2 Recombinant Protein Vaccines with Adjuvant in Adults 18 Years of Age and Older - LC 3

$3,544,100
Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI

Development of rationally designed HIV vaccines

$3,542,953
Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Epidemiology and Natural History of Cancer-Associated Viruses

$3,542,746
Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Boston HIV CTU

$3,541,665
Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2024 · AI

Harvard University Center for AIDS Research

$3,540,479
Bruce D Walker · Harvard University · P30 · FY2017 · AI

Harvard University Center for AIDS Research

$3,540,479
Bruce D Walker · Harvard University · P30 · FY2018 · AI

Translational Methamphetamine AIDS Research Center (TMARC)

$3,539,475
Igor Grant · University Of California, San Diego · P50 · FY2018 · DA

Stat transcription factors in immunoregulation and autoimmune disease

$3,535,246
John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2018 · AR

HARC Center: HIV Accessory and Regulatory Complexes

$3,534,909
Alan D Frankel · University Of California, San Francisco · P50 · FY2010 · GM

ZDV USE TO PREVENT MATERNAL/INFANT HIV TRANSMISSION

$3,534,704
Andrea Jenay Ruff · Johns Hopkins University · U01 · FY2006 · AI

Miami Clinical and Translational Science Institute

$3,534,205
Ralph Lewis Sacco · University Of Miami School Of Medicine · UL1 · FY2021 · TR

Project-002

$3,534,143
Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2024 · DA